KR101376479B1 - 뮤 오피오이드 수용체 안타고니스트인 ８­아자비시클로［３．２．１］옥탄 화합물 - Google Patents

뮤 오피오이드 수용체 안타고니스트인 ８­아자비시클로［３．２．１］옥탄 화합물 Download PDF

Info

Publication number
KR101376479B1
KR101376479B1 KR1020087024027A KR20087024027A KR101376479B1 KR 101376479 B1 KR101376479 B1 KR 101376479B1 KR 1020087024027 A KR1020087024027 A KR 1020087024027A KR 20087024027 A KR20087024027 A KR 20087024027A KR 101376479 B1 KR101376479 B1 KR 101376479B1
Authority
KR
South Korea
Prior art keywords
endo
azabicyclo
oct
ethyl
benzamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020087024027A
Other languages
English (en)
Korean (ko)
Other versions
KR20080100282A (ko
Inventor
다니엘 롱
티모시 제이. 쳐치
존 알. 야콥센
란 지앙
다이스케 롤랜드 사이토
이오안나 스터지아데스
다이크 프리실라 반
션 달지엘
레티샤 프레자
Original Assignee
세라밴스 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38436795&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101376479(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 세라밴스 인코포레이티드 filed Critical 세라밴스 인코포레이티드
Publication of KR20080100282A publication Critical patent/KR20080100282A/ko
Application granted granted Critical
Publication of KR101376479B1 publication Critical patent/KR101376479B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR1020087024027A 2006-03-01 2007-02-28 뮤 오피오이드 수용체 안타고니스트인 ８­아자비시클로［３．２．１］옥탄 화합물 Active KR101376479B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US77796206P 2006-03-01 2006-03-01
US60/777,962 2006-03-01
US84102806P 2006-08-30 2006-08-30
US60/841,028 2006-08-30
PCT/US2007/005388 WO2007103187A2 (en) 2006-03-01 2007-02-28 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Publications (2)

Publication Number Publication Date
KR20080100282A KR20080100282A (ko) 2008-11-14
KR101376479B1 true KR101376479B1 (ko) 2014-03-27

Family

ID=38436795

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087024027A Active KR101376479B1 (ko) 2006-03-01 2007-02-28 뮤 오피오이드 수용체 안타고니스트인 ８­아자비시클로［３．２．１］옥탄 화합물

Country Status (24)

Country Link
US (11) US7622508B2 (enExample)
EP (1) EP2001876B1 (enExample)
JP (2) JP5086280B2 (enExample)
KR (1) KR101376479B1 (enExample)
AR (1) AR059690A1 (enExample)
AT (1) ATE509928T1 (enExample)
AU (1) AU2007224213B2 (enExample)
BR (1) BRPI0708490B8 (enExample)
CA (1) CA2646409C (enExample)
CY (1) CY1111747T1 (enExample)
DK (1) DK2001876T3 (enExample)
HR (1) HRP20110590T1 (enExample)
IL (1) IL193690A (enExample)
MA (1) MA30284B1 (enExample)
MX (1) MX2008011165A (enExample)
MY (1) MY145633A (enExample)
NZ (1) NZ570764A (enExample)
PE (1) PE20071311A1 (enExample)
PL (1) PL2001876T3 (enExample)
PT (1) PT2001876E (enExample)
RU (1) RU2423362C2 (enExample)
SI (1) SI2001876T1 (enExample)
TW (1) TWI379832B (enExample)
WO (1) WO2007103187A2 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY145633A (en) * 2006-03-01 2012-03-15 Theravance Inc 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
TWI409067B (zh) * 2007-02-28 2013-09-21 Theravance Inc ８-氮雜雙環〔３．２．１〕辛烷化合物之結晶型
TWI415850B (zh) * 2007-07-20 2013-11-21 Theravance Inc 製備ｍｕ類鴉片受體拮抗劑之中間物的方法
TWI423801B (zh) 2007-08-27 2014-01-21 Theravance Inc 作為μ類鴉片受體拮抗劑之８－氮雜雙環〔３．２．１〕辛基－２－羥基苯甲醯胺化合物
US7947710B2 (en) * 2007-08-27 2011-05-24 Theravance, Inc. Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
EP2195313B1 (en) * 2007-08-27 2014-04-02 Theravance, Inc. Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
ES2390195T3 (es) * 2007-08-27 2012-11-07 Theravance, Inc. Compuestos de amidoalquil-8-azabiciclo(3,2,1)octano, como antagonistas del receptor opioide mu
WO2011035142A1 (en) * 2009-09-18 2011-03-24 Adolor Corporation Use of opioid receptor antagonist for gastrointestinal tract disorders
US20120122928A1 (en) 2010-08-11 2012-05-17 Bayer Cropscience Ag Heteroarylpiperidine and -Piperazine Derivatives as Fungicides
US8759527B2 (en) 2010-08-25 2014-06-24 Bayer Cropscience Ag Heteroarylpiperidine and -piperazine derivatives as fungicides
EP2423210A1 (de) 2010-08-25 2012-02-29 Bayer CropScience AG Heteroarylpiperidin- und -piperazinderivate als Fungizide
MX352731B (es) 2010-10-27 2017-12-06 Bayer Ip Gmbh Derivados de heteroarilpiperidina y -piperazina como fungicidas.
JP5703009B2 (ja) * 2010-12-16 2015-04-15 住友精化株式会社 スルホン化合物、スルホン化合物の製造方法、および電気化学デバイス用電解液
KR101848116B1 (ko) 2011-02-01 2018-04-11 바이엘 인텔렉쳐 프로퍼티 게엠베하 살진균제로서의 헤테로아릴 피페리딘 및 헤테로아릴 피페라진 유도체
IN2014CN01862A (enExample) 2011-09-15 2015-05-29 Bayer Ip Gmbh
EP2921492B1 (de) 2011-12-27 2017-09-06 Bayer Intellectual Property GmbH Heteroarylpiperidin- und -heteroarylpiperazinderivate
US9192570B2 (en) 2013-12-20 2015-11-24 AntiOP, Inc. Intranasal naloxone compositions and methods of making and using same
PT3277278T (pt) 2015-04-02 2020-04-16 Theravance Biopharma R&D Ip Llc Forma farmacêutica de combinação de um antagonista do recetor opioide mu e um agente opioide
SG11202007422QA (en) 2018-02-05 2020-09-29 Alkermes Inc Compounds for the treatment of pain
EP4240740A4 (en) * 2020-11-06 2024-12-11 Actinogen Medical Limited PROCESS FOR PREPARING HETEROCYCLIC METHANONE COMPOUNDS AND AZABICYCLO INTERMEDIATES THEREOF

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004089908A2 (en) * 2003-04-14 2004-10-21 Pfizer Products Inc. 3-azabicyclo[3.2.1]octane derivatives

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1067824B (de) * 1954-10-20 1959-10-29 Sandoz Ag Verfahren zur Herstellung saeureamidartiger Tropanabkoemmlinge
US5159081A (en) 1991-03-29 1992-10-27 Eli Lilly And Company Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
UA58476C2 (uk) * 1997-10-09 2003-08-15 Санофі-Сентелябо Похідні 8-азабіцикло[3.2.1]октан-3-метанаміну, фармацевтична композиція та лікарський засіб
US6900228B1 (en) 1998-03-10 2005-05-31 Research Triangle Institute Opiate compounds, methods of making and methods of use
GB9810671D0 (en) 1998-05-18 1998-07-15 Pfizer Ltd Anti-pruritic agents
TWI244481B (en) 1998-12-23 2005-12-01 Pfizer 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
GB9912410D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
US6469030B2 (en) 1999-11-29 2002-10-22 Adolor Corporation Methods for the treatment and prevention of ileus
KR20030009376A (ko) 2000-03-03 2003-01-29 오르토-맥네일 파마슈티칼, 인코퍼레이티드 3-(디아릴메틸렌)-8-아자비사이클로[3.2.1]옥탄 유도체
US20030181447A1 (en) * 2001-02-22 2003-09-25 Boyd Robert E. 3-(Diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives
US20020025948A1 (en) 2000-06-23 2002-02-28 Banks Bernard Joseph 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
JP4009251B2 (ja) 2001-10-09 2007-11-14 杏林製薬株式会社 新規な４−（２−フロイル）アミノピペリジン、その合成中間体、その製造方法および医薬としてのその用途
GEP20084300B (en) 2001-10-22 2008-02-11 Pfizer Prod Inc 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists
US7381721B2 (en) 2003-03-17 2008-06-03 Adolor Corporation Substituted piperidine compounds
US20040204453A1 (en) 2003-04-14 2004-10-14 Pfizer Inc 4-Phenyl-piperidine compounds and their use as modulators of opioid receptors
US7056930B2 (en) 2003-04-14 2006-06-06 Pfizer Inc. 2-Azabicyclo[3.3.1]nonane derivatives
CA2522199A1 (en) 2003-04-15 2004-10-28 Pfizer Products Inc. 3-benzhydrylidene-8-aza-bicyclo¬3.2.1|octane derivatives with opioid receptor activity
US6992090B2 (en) 2003-06-16 2006-01-31 Adolor Corporation Substituted piperidine compounds and methods of their use
EP1737853A1 (en) 2004-02-03 2007-01-03 Janssen Pharmaceutica N.V. 3-(diheteroarylmethylene)-8-azabicyclo¬3.2.1|octane and 3-((aryl)(heteroaryl)methylene)-8-azabicyclo¬3.2.1|octane derivatives
US7087749B2 (en) 2004-03-11 2006-08-08 Adolor Corporation Substituted piperidine compounds and methods of their use
US7538110B2 (en) 2005-10-27 2009-05-26 Adolor Corporation Opioid antagonists
MY145633A (en) 2006-03-01 2012-03-15 Theravance Inc 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
MX2009004965A (es) 2006-11-07 2009-06-05 Nektar Therapeutics Al Corp Formas de dosificacion y co-administracion de un agonista de opioides y un antagonista de opioides.
TWI409067B (zh) 2007-02-28 2013-09-21 Theravance Inc ８-氮雜雙環〔３．２．１〕辛烷化合物之結晶型
TWI415850B (zh) * 2007-07-20 2013-11-21 Theravance Inc 製備ｍｕ類鴉片受體拮抗劑之中間物的方法
EP2195313B1 (en) * 2007-08-27 2014-04-02 Theravance, Inc. Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
US7947710B2 (en) * 2007-08-27 2011-05-24 Theravance, Inc. Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
TWI423801B (zh) * 2007-08-27 2014-01-21 Theravance Inc 作為μ類鴉片受體拮抗劑之８－氮雜雙環〔３．２．１〕辛基－２－羥基苯甲醯胺化合物
ES2390195T3 (es) 2007-08-27 2012-11-07 Theravance, Inc. Compuestos de amidoalquil-8-azabiciclo(3,2,1)octano, como antagonistas del receptor opioide mu

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004089908A2 (en) * 2003-04-14 2004-10-21 Pfizer Products Inc. 3-azabicyclo[3.2.1]octane derivatives

Also Published As

Publication number Publication date
US20190119267A1 (en) 2019-04-25
WO2007103187A2 (en) 2007-09-13
PE20071311A1 (es) 2007-12-29
RU2008138875A (ru) 2010-04-10
US8664242B2 (en) 2014-03-04
WO2007103187A3 (en) 2007-11-01
US20170349578A1 (en) 2017-12-07
US20210024515A1 (en) 2021-01-28
US8263618B2 (en) 2012-09-11
JP2012211193A (ja) 2012-11-01
ATE509928T1 (de) 2011-06-15
US20160176863A1 (en) 2016-06-23
US10377751B2 (en) 2019-08-13
US10081626B2 (en) 2018-09-25
TW200800981A (en) 2008-01-01
HRP20110590T1 (hr) 2011-09-30
US20130158060A1 (en) 2013-06-20
SI2001876T1 (sl) 2011-09-30
US8927573B2 (en) 2015-01-06
BRPI0708490B8 (pt) 2021-05-25
IL193690A0 (en) 2009-08-03
TWI379832B (en) 2012-12-21
US20140288112A1 (en) 2014-09-25
RU2423362C2 (ru) 2011-07-10
EP2001876B1 (en) 2011-05-18
US20230183232A1 (en) 2023-06-15
US11548887B2 (en) 2023-01-10
US20100035921A1 (en) 2010-02-11
MX2008011165A (es) 2008-09-15
CA2646409A1 (en) 2007-09-13
US20150291579A1 (en) 2015-10-15
BRPI0708490A2 (pt) 2011-05-31
US10745394B2 (en) 2020-08-18
AU2007224213A1 (en) 2007-09-13
JP2009528371A (ja) 2009-08-06
US7622508B2 (en) 2009-11-24
PL2001876T3 (pl) 2011-10-31
AR059690A1 (es) 2008-04-23
US20190308966A1 (en) 2019-10-10
KR20080100282A (ko) 2008-11-14
PT2001876E (pt) 2011-08-18
IL193690A (en) 2013-02-28
MA30284B1 (fr) 2009-03-02
BRPI0708490B1 (pt) 2019-07-30
US20070219278A1 (en) 2007-09-20
US9663509B2 (en) 2017-05-30
DK2001876T3 (da) 2011-08-29
MY145633A (en) 2012-03-15
CY1111747T1 (el) 2015-10-07
HK1125935A1 (en) 2009-08-21
AU2007224213B2 (en) 2012-06-14
NZ570764A (en) 2011-08-26
JP5086280B2 (ja) 2012-11-28
US9206172B2 (en) 2015-12-08
EP2001876A2 (en) 2008-12-17
CA2646409C (en) 2015-11-10

Similar Documents

Publication Publication Date Title
KR101376479B1 (ko) 뮤 오피오이드 수용체 안타고니스트인 ８­아자비시클로［３．２．１］옥탄 화합물
AU2008293974B2 (en) 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
ES2465621T3 (es) Compuestos de heteroarilalquil-8-azabiciclo[3.2.1]octano, como antagonistas de los receptores opiodes mu
EP2185553B1 (en) Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
CN101395154B (zh) 作为μ阿片受体拮抗剂的8-氮杂双环[3.2.1]辛烷化合物
HK1125935B (en) 8-azabicyclo [3.2.1] octane compounds as mu opioid receptor antagonists

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20080930

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20120202

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20130719

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20131226

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20140314

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20140317

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20170308

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20170308

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20200228

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20200228

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20240228

Start annual number: 11

End annual number: 11